These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6292744)

  • 21. Diltiazem potentiates the negative inotropic action of nimodipine in heart.
    DePover A; Grupp IL; Grupp G; Schwartz A
    Biochem Biophys Res Commun; 1983 Aug; 114(3):922-9. PubMed ID: 6615515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temperature-dependent regulation of d-cis-[3H]diltiazem binding to Ca2+ channels by 1,4-dihydropyridine channel agonists and antagonists.
    Glossmann H; Linn T; Rombusch M; Ferry DR
    FEBS Lett; 1983 Aug; 160(1-2):226-32. PubMed ID: 6309565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. (-)-[3H]Desmethoxyverapamil, a novel Ca2+ channel probe. Binding characteristics and target size analysis of its receptor in skeletal muscle.
    Goll A; Ferry DR; Striessnig J; Schober M; Glossmann H
    FEBS Lett; 1984 Oct; 176(2):371-7. PubMed ID: 6092142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct inhibition of 5-hydroxytryptamine3 receptors by antagonists of L-type Ca2+ channels.
    Hargreaves AC; Gunthorpe MJ; Taylor CW; Lummis SC
    Mol Pharmacol; 1996 Nov; 50(5):1284-94. PubMed ID: 8913360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of diltiazem and verapamil on (+)-PN 200-110 binding kinetics in dog cardiac membranes.
    Miwa K; Miyagi Y; Araie E; Sasayama S
    Eur J Pharmacol; 1992 Apr; 214(2-3):127-32. PubMed ID: 1325351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Target size analysis of skeletal muscle Ca2+ channels. Positive allosteric heterotropic regulation by d-cis-diltiazem is associated with apparent channel oligomer dissociation.
    Goll A; Ferry DR; Glossmann H
    FEBS Lett; 1983 Jun; 157(1):63-9. PubMed ID: 6305718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [3H]-Nimodipine and [3H]-nitrendipine as tools to directly identify the sites of action of 1,4-dihydropyridine calcium antagonists in guinea-pig tissues. Tissue-specific effects of anions and ionic strength.
    Bellemann P; Ferry D; Lübbecke F; Glossmann H
    Arzneimittelforschung; 1982; 32(4):361-3. PubMed ID: 7201804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allosteric modulation by diltiazem and verapamil of [3H]nitrendipine binding to calcium channel sites in rat brain.
    Schoemaker H; Boles RG; Roeske WR; Yamamura HI
    Proc West Pharmacol Soc; 1983; 26():219-24. PubMed ID: 6310626
    [No Abstract]   [Full Text] [Related]  

  • 29. Ca2+ channel antagonist actions in bladder smooth muscle: comparative pharmacologic and [3H]nitrendipine binding studies.
    Yousif FB; Bolger GT; Ruzycky A; Triggle DJ
    Can J Physiol Pharmacol; 1985 May; 63(5):453-62. PubMed ID: 2994869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison between the binding and electrophysiological effects of dihydropyridines on cardiac membranes.
    Hamilton SL; Yatani A; Brush K; Schwartz A; Brown AM
    Mol Pharmacol; 1987 Mar; 31(3):221-31. PubMed ID: 2436031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Voltage-dependent cooperative interactions of calcium channel ligands in intact cardiac cells.
    Porzig H; Kokubun S; Prod'hom B; Becker C; Reuter H
    Biomed Biochim Acta; 1987; 46(8-9):S370-4. PubMed ID: 2449182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle.
    Bolger GT; Gengo P; Klockowski R; Luchowski E; Siegel H; Janis RA; Triggle AM; Triggle DJ
    J Pharmacol Exp Ther; 1983 May; 225(2):291-309. PubMed ID: 6842393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcium channel antagonists and the treatment of migraine.
    Greenberg DA
    Clin Neuropharmacol; 1986; 9(4):311-28. PubMed ID: 2425960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Slow calcium channel blockers and the calcium paradox: comparative studies in the rat with seven drugs.
    Baker JE; Hearse DJ
    J Mol Cell Cardiol; 1983 Jul; 15(7):475-85. PubMed ID: 6312058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purification of the putative calcium channel from skeletal muscle with the aid of [3H]-nimodipine binding.
    Glossmann H; Ferry DR; Boschek CB
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Jun; 323(1):1-11. PubMed ID: 6308477
    [No Abstract]   [Full Text] [Related]  

  • 36. gamma-Aminobutyric acid release from synaptosomes as influenced by Ca2+ and Ca2+ channel blockers.
    Carvalho CM; Santos SV; Carvalho AP
    Eur J Pharmacol; 1986 Nov; 131(1):1-12. PubMed ID: 3816939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diltiazem enhancement of [3H]nitrendipine binding to calcium channel associated drug receptor sites in rat brain synaptosomes.
    Yamamura HI; Schoemaker H; Boles RG; Roeske WR
    Biochem Biophys Res Commun; 1982 Sep; 108(2):640-6. PubMed ID: 6293498
    [No Abstract]   [Full Text] [Related]  

  • 38. A simple sensitive radioreceptor assay for calcium antagonist drugs.
    Gould RJ; Murphy KM; Snyder SH
    Life Sci; 1983 Dec; 33(26):2665-72. PubMed ID: 6319847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human red-blood-cell Ca2+-antagonist binding sites. Evidence for an unusual receptor coupled to the nucleoside transporter.
    Striessnig J; Zernig G; Glossmann H
    Eur J Biochem; 1985 Jul; 150(1):67-77. PubMed ID: 2990927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction between calcium channel ligands and calcium channels.
    Glossmann H; Striessnig J; Ferry DR; Goll A; Moosburger K; Schirmer M
    Circ Res; 1987 Oct; 61(4 Pt 2):I30-6. PubMed ID: 2443273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.